Is the Sunshine State going green?? The Miami Herald News

New Post Public Reply Private Reply Replies (2) Message Board
Howiesjules

Is the Sunshine State going green??

The Miami Herald > News > Florida

.backHome{padding-left:10px;}.backHome a {font-size:12px; font-weight:bold;color:#007ACA;}.backHome a:hover{color:#054873;}.section-front .backHome {margin-bottom:15px;} .subnav{margin-bottom:8px;} .breadcrumb-section995{display:none;}

MEDICAL MARIJUANA

Obama donor and Charlie Crist boss backs medical marijuana plan

mcaputo@MiamiHerald.com

John Morgan, a major fundraiser for President Barack Obama and the boss of former Gov. Charlie Crist, is taking the reins of a Florida medical marijuana initiative, promising to pump major money and political muscle into the popular issue.

Morgan, a top Florida trial lawyer based in Orlando, said he’s ready to tap a network of donors and his personal bank account to get the measure in front of voters in 2014 as a proposed constitutional amendment.

“I can get the money. I have the money. I will be joined by people with money who will help,” said Morgan. “I’ve been very fortunate in life, and I can make it happen.”

It could cost as much as $3.5 million to fund paid-petition gatherers to collect the valid signatures of 683,149 Florida voters needed to get a measure on the ballot. An ad and absentee-ballot campaign could cost up to $10 million more.

Constitutional amendments need to be approved in Florida with 60 percent of the vote.

Morgan said he hasn’t spoken about the issue with Crist or Obama, with whom he had dinner Monday. And, he said, he doesn’t care whether they support it or not.

Crist, a Republican-turned-independent-turned Democrat, is considering a run for governor. He wouldn’t return calls for comment.

Morgan, however, has spoken to former Florida House Speaker and past University of Florida law school dean Jon Mills, a state constitutional expert who will help write the amendment ballot summary to help ensure it passes muster at the Florida Supreme Court.

Morgan, head of the Morgan & Morgan firm, said he’s going to lead the initiative for personal reasons: His father had struggled with cancer and emphysema, and only marijuana helped him.

“He was tethered to machines and on all these drugs that he had no appetite,” Morgan said. “One of my brothers was able to get marijuana for him so he could eat and be happy.”

Though Morgan’s a top Democrat, the medical marijuana initiative has backing from Republicans and independents as well, according to a poll completed last month by the group that Morgan is scheduled to lead, People United for Medical Marijuana, called PUFMM.

The survey showed that 73 percent of Florida voters would approve of the proposal allowing doctors to recommend marijuana for medicinal use. Support cuts across party, demographic and regional lines.

To date, 18 states plus the District of Columbia have medical-marijuana laws, including Republican-leaning states like Arizona. Most of the laws have been approved by voters, not politicians. Even recreational marijuana use got approval of voters in Colorado and Washington last November.

“Florida is a top four state,” Morgan said. “This is a domino that could fall in Florida and really have a big effect around the country.”

Critics hope that doesn’t happen.

Bill Bunkley, a prominent Florida evangelical radio personality, recently spoke out against the effort.

Without mentioning Crist’s name, Bunkley noted that the issue could help a Democratic candidate for governor. And, he said, medical marijuana laws can lead to a type of legalization, which a majority of Floridians still oppose when asked if they want pot legalized outright.

“Just say ‘No’ still applies here in Florida,” Bunkley wrote last month.

Rapid Fire Marketing, Inc. (RFMK) Stock Research Links

RFMK Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 3

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 6

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 3

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 12

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
More News Articles